How to manage tianeptine withdrawal in a patient with adrenal insufficiency on high-dose steroids (hydrocortisone 100 mg twice daily) and midodrine (5 mg three times daily)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Managing Tianeptine Withdrawal in a Patient with Adrenal Insufficiency

Continue the current high-dose hydrocortisone 100 mg twice daily without tapering during tianeptine withdrawal, as this represents appropriate stress-dose coverage for a major physiological stressor, and maintain midodrine for blood pressure support while managing withdrawal symptoms with buprenorphine/naloxone or supportive care. 1, 2

Maintain Stress-Dose Glucocorticoid Coverage

The current hydrocortisone regimen of 100 mg twice daily (200 mg total daily) is appropriate and should be continued throughout the withdrawal period without reduction. 1

  • Tianeptine withdrawal constitutes a major physiological stress comparable to severe illness or surgery, which requires stress-dose glucocorticoid coverage in patients with adrenal insufficiency 1, 2, 3
  • The consensus guidelines for primary adrenal insufficiency recommend 100 mg hydrocortisone every 6 hours (400 mg daily) for major surgery or severe stress, continuing until the patient is stable 1
  • Your patient's current dose of 200 mg daily represents an intermediate stress dose that is reasonable for managing withdrawal 1, 4
  • Do not taper the hydrocortisone until withdrawal symptoms have completely resolved and the patient is clinically stable for at least 24-48 hours 1, 4

Critical Monitoring for Adrenal Crisis

Remain vigilant for signs of adrenal crisis, as withdrawal symptoms can mask or mimic crisis symptoms, and nausea/vomiting during withdrawal poses particular risk. 1

  • Nausea and vomiting occur in tianeptine withdrawal and are also precipitating events for adrenal crisis in 6-8 per 100 patient-years 1, 5, 3
  • If the patient develops persistent vomiting and cannot absorb oral hydrocortisone, immediately switch to IV hydrocortisone 100 mg bolus followed by 100 mg every 6 hours 1
  • Monitor for confusion, severe weakness, hypotension, or altered mental status—these require immediate IV hydrocortisone and aggressive fluid resuscitation with 0.9% saline at 1 L/hour 1
  • Never delay treatment of suspected adrenal crisis for diagnostic procedures—the mortality is high if untreated 1

Tianeptine Withdrawal Management Protocol

Treat tianeptine withdrawal with buprenorphine/naloxone as first-line therapy, as tianeptine has opioid agonist activity and withdrawal resembles opioid withdrawal. 2, 3

  • The most recent case report (2025) successfully managed severe tianeptine withdrawal (8-20 g daily use) with buprenorphine/naloxone, with symptom improvement within 3 days 2
  • Start buprenorphine/naloxone once the patient is in moderate withdrawal (typically 12-24 hours after last tianeptine dose) to avoid precipitated withdrawal 2
  • Alternative supportive management includes phenothiazines (cyamemazine) for sedation and benzodiazepines (tetrazepam) for myalgia and muscle relaxation if buprenorphine is contraindicated 5
  • Withdrawal symptoms include myalgia, cold feeling, nausea, vomiting, abdominal pain, and anxiety—these typically resolve over 4-7 days with appropriate treatment 5, 3

Midodrine Management During Withdrawal

Continue midodrine 5 mg three times daily for blood pressure support, as both adrenal insufficiency and tianeptine withdrawal can cause hypotension. 1

  • Midodrine provides alpha-agonist support for orthostatic hypotension, which is common in adrenal insufficiency even with adequate glucocorticoid replacement 1
  • Monitor blood pressure in supine and standing positions to assess for orthostatic changes 4
  • Once withdrawal is complete and the patient is stable on maintenance hydrocortisone, reassess the need for midodrine by checking for orthostatic hypotension and considering fludrocortisone optimization 4

Tapering Strategy After Withdrawal Resolution

Once tianeptine withdrawal symptoms have completely resolved and the patient is clinically stable for 48 hours, begin tapering hydrocortisone to maintenance dosing over 3-5 days. 1, 4

  • Taper from 100 mg twice daily to double the maintenance dose (40-50 mg daily in divided doses) for 24-48 hours 1
  • Then reduce to standard maintenance dosing of 15-25 mg daily, typically given as 10 mg upon awakening and 5 mg in early afternoon 4, 6
  • If the patient has primary adrenal insufficiency, ensure fludrocortisone 0.05-0.1 mg daily is prescribed for mineralocorticoid replacement 4, 6
  • Monitor for signs of under-replacement (fatigue, nausea, orthostatic hypotension) or over-replacement (weight gain, hypertension, hyperglycemia) during the taper 4, 6

Critical Pitfalls to Avoid

  • Do not prematurely taper steroids while withdrawal symptoms are active—this risks precipitating adrenal crisis during a period of high physiological stress 1
  • Do not assume the patient can absorb oral medications if vomiting occurs—switch to parenteral hydrocortisone immediately 1
  • Do not rely on electrolyte abnormalities to diagnose adrenal crisis—hyperkalemia is present in only 50% of cases and hyponatremia may be mild 1, 7
  • Do not discharge the patient without ensuring they have emergency injectable hydrocortisone, medical alert identification, and education on stress dosing 1, 4, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hydrocortisone Dosing for Addison's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of ACTH-Dependent Relative Adrenal Insufficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Adrenal Insufficiency in Hypo-osmolar Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended treatment for adrenal insufficiency using dexamethasone?
What is the primary treatment for adrenal insufficiency?
What are the next best steps to ensure optimal cardiovascular health in a patient with primary adrenal insufficiency on 22.5mg hydrocortisone (cortisol) and 0.1mg fludrocortisone (fludrocortisone), with normal blood pressure?
What is the treatment for adrenal insufficiency?
What is the protocol for managing adrenal insufficiency (Addison's disease) and preventing crisis?
What is the best course of action for a 28-year-old male with recurrent episodes of epigastric pain, sour taste, and bloating, who has tried Gaviscon (aluminum hydroxide and magnesium carbonate) and Kremil-S (sucralfate) with only mild relief, and has a history of daily coffee consumption?
What are the recommendations for the use of beta (beta blockers) in patients with hypertension, heart failure, or arrhythmias during the perioperative period?
What is the recommended insulin dosing for a 49-year-old, 80 kg male patient with new-onset diabetes, severe hyperglycemia (glucose level of 628), and not in diabetic ketoacidosis (DKA)?
What is the initial treatment approach for a newly diagnosed patient with leukemia, without significant comorbidities?
What is the insulin of choice and dosage for patients with varying blood glucose levels, including hyperglycemia (above 250 mg/dL), mild hyperglycemia (between 100-200 mg/dL), and severe hyperglycemia (above 400 mg/dL)?
What is the appropriate levothyroxine (thyroid hormone replacement medication) titration for an elderly patient with hypothyroidism (elevated Thyroid-Stimulating Hormone (TSH) level) and a TSH level of 9.583, currently prescribed 112 micrograms (mcg) of levothyroxine daily?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.